nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ALB—hematologic cancer	0.108	0.512	CbGaD
Captopril—ABCB1—hematologic cancer	0.103	0.488	CbGaD
Captopril—ABCB1—Lenalidomide—hematologic cancer	0.0233	0.0699	CbGbCtD
Captopril—CYP2D6—Lomustine—hematologic cancer	0.0204	0.0612	CbGbCtD
Captopril—ALB—Imatinib—hematologic cancer	0.02	0.06	CbGbCtD
Captopril—CYP2D6—Idarubicin—hematologic cancer	0.0182	0.0545	CbGbCtD
Captopril—CYP2D6—Hydroxyurea—hematologic cancer	0.0155	0.0464	CbGbCtD
Captopril—ABCB1—Daunorubicin—hematologic cancer	0.0137	0.041	CbGbCtD
Captopril—CYP2D6—Bortezomib—hematologic cancer	0.0135	0.0403	CbGbCtD
Captopril—ABCB1—Alitretinoin—hematologic cancer	0.0134	0.0401	CbGbCtD
Captopril—ALB—Prednisone—hematologic cancer	0.0132	0.0395	CbGbCtD
Captopril—ALB—Irinotecan—hematologic cancer	0.0125	0.0375	CbGbCtD
Captopril—ABCB1—Imatinib—hematologic cancer	0.0105	0.0314	CbGbCtD
Captopril—CYP2D6—Imatinib—hematologic cancer	0.00986	0.0296	CbGbCtD
Captopril—ABCB1—Nilotinib—hematologic cancer	0.00951	0.0285	CbGbCtD
Captopril—ABCB1—Vinorelbine—hematologic cancer	0.00943	0.0283	CbGbCtD
Captopril—CYP2D6—Nilotinib—hematologic cancer	0.00896	0.0269	CbGbCtD
Captopril—CYP2D6—Vinorelbine—hematologic cancer	0.00888	0.0266	CbGbCtD
Captopril—ABCB1—Dasatinib—hematologic cancer	0.0084	0.0252	CbGbCtD
Captopril—ABCB1—Mitoxantrone—hematologic cancer	0.0083	0.0249	CbGbCtD
Captopril—SLC22A6—Methotrexate—hematologic cancer	0.00776	0.0233	CbGbCtD
Captopril—ABCB1—Betamethasone—hematologic cancer	0.0074	0.0222	CbGbCtD
Captopril—ABCB1—Gemcitabine—hematologic cancer	0.00733	0.022	CbGbCtD
Captopril—ABCB1—Prednisolone—hematologic cancer	0.0073	0.0219	CbGbCtD
Captopril—ABCB1—Prednisone—hematologic cancer	0.00689	0.0207	CbGbCtD
Captopril—ALB—Methotrexate—hematologic cancer	0.00661	0.0198	CbGbCtD
Captopril—ABCB1—Irinotecan—hematologic cancer	0.00654	0.0196	CbGbCtD
Captopril—ABCB1—Vinblastine—hematologic cancer	0.00581	0.0174	CbGbCtD
Captopril—ABCB1—Vincristine—hematologic cancer	0.00571	0.0171	CbGbCtD
Captopril—CYP2D6—Vinblastine—hematologic cancer	0.00548	0.0164	CbGbCtD
Captopril—ABCB1—Cisplatin—hematologic cancer	0.00533	0.016	CbGbCtD
Captopril—ABCB1—Etoposide—hematologic cancer	0.00523	0.0157	CbGbCtD
Captopril—ABCB1—Dexamethasone—hematologic cancer	0.0043	0.0129	CbGbCtD
Captopril—CYP2D6—Dexamethasone—hematologic cancer	0.00406	0.0122	CbGbCtD
Captopril—LTA4H—hematopoietic system—hematologic cancer	0.00372	0.0634	CbGeAlD
Captopril—ABCB1—Doxorubicin—hematologic cancer	0.00357	0.0107	CbGbCtD
Captopril—ABCB1—Methotrexate—hematologic cancer	0.00346	0.0104	CbGbCtD
Captopril—CYP2D6—Doxorubicin—hematologic cancer	0.00336	0.0101	CbGbCtD
Captopril—REN—hematopoietic system—hematologic cancer	0.00287	0.049	CbGeAlD
Captopril—LTA4H—gonad—hematologic cancer	0.00283	0.0482	CbGeAlD
Captopril—MMP2—hematopoietic system—hematologic cancer	0.00264	0.045	CbGeAlD
Captopril—LTA4H—blood—hematologic cancer	0.00247	0.042	CbGeAlD
Captopril—LTA4H—bone marrow—hematologic cancer	0.00239	0.0407	CbGeAlD
Captopril—MMP9—hematopoietic system—hematologic cancer	0.0023	0.0391	CbGeAlD
Captopril—LTA4H—lung—hematologic cancer	0.00216	0.0368	CbGeAlD
Captopril—LTA4H—testis—hematologic cancer	0.00204	0.0348	CbGeAlD
Captopril—MMP2—gonad—hematologic cancer	0.00201	0.0342	CbGeAlD
Captopril—F2—hematopoietic system—hematologic cancer	0.002	0.0342	CbGeAlD
Captopril—REN—blood—hematologic cancer	0.0019	0.0324	CbGeAlD
Captopril—MMP2—blood—hematologic cancer	0.00175	0.0298	CbGeAlD
Captopril—REN—lung—hematologic cancer	0.00167	0.0284	CbGeAlD
Captopril—MMP2—lung—hematologic cancer	0.00153	0.0261	CbGeAlD
Captopril—MMP9—blood—hematologic cancer	0.00152	0.0259	CbGeAlD
Captopril—LTA4H—lymph node—hematologic cancer	0.00148	0.0252	CbGeAlD
Captopril—MMP9—bone marrow—hematologic cancer	0.00147	0.0251	CbGeAlD
Captopril—MMP2—testis—hematologic cancer	0.00145	0.0247	CbGeAlD
Captopril—MMP9—lung—hematologic cancer	0.00133	0.0227	CbGeAlD
Captopril—F2—blood—hematologic cancer	0.00133	0.0226	CbGeAlD
Captopril—F2—bone marrow—hematologic cancer	0.00129	0.0219	CbGeAlD
Captopril—MMP9—testis—hematologic cancer	0.00126	0.0215	CbGeAlD
Captopril—ACE—hematopoietic system—hematologic cancer	0.00122	0.0209	CbGeAlD
Captopril—F2—lung—hematologic cancer	0.00116	0.0198	CbGeAlD
Captopril—MMP2—lymph node—hematologic cancer	0.00105	0.0179	CbGeAlD
Captopril—ACE—gonad—hematologic cancer	0.000931	0.0159	CbGeAlD
Captopril—MMP9—lymph node—hematologic cancer	0.000913	0.0156	CbGeAlD
Captopril—ACE—blood—hematologic cancer	0.000811	0.0138	CbGeAlD
Captopril—ACE—bone marrow—hematologic cancer	0.000785	0.0134	CbGeAlD
Captopril—ACE—lung—hematologic cancer	0.000711	0.0121	CbGeAlD
Captopril—ALB—testis—hematologic cancer	0.000701	0.0119	CbGeAlD
Captopril—ACE—testis—hematologic cancer	0.000671	0.0114	CbGeAlD
Captopril—CYP2D6—hematopoietic system—hematologic cancer	0.000599	0.0102	CbGeAlD
Captopril—ALB—lymph node—hematologic cancer	0.000508	0.00866	CbGeAlD
Captopril—ACE—lymph node—hematologic cancer	0.000486	0.00829	CbGeAlD
Captopril—ABCB1—hematopoietic system—hematologic cancer	0.000431	0.00735	CbGeAlD
Captopril—CYP2D6—blood—hematologic cancer	0.000397	0.00677	CbGeAlD
Captopril—CYP2D6—testis—hematologic cancer	0.000328	0.0056	CbGeAlD
Captopril—ABCB1—gonad—hematologic cancer	0.000328	0.00559	CbGeAlD
Captopril—ABCB1—blood—hematologic cancer	0.000286	0.00487	CbGeAlD
Captopril—ABCB1—bone marrow—hematologic cancer	0.000276	0.00471	CbGeAlD
Captopril—MMP2—Dexamethasone—Betamethasone—hematologic cancer	0.000262	0.131	CbGdCrCtD
Captopril—MMP2—Betamethasone—Dexamethasone—hematologic cancer	0.000262	0.131	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Triamcinolone—hematologic cancer	0.000256	0.128	CbGdCrCtD
Captopril—MMP2—Betamethasone—Triamcinolone—hematologic cancer	0.000256	0.128	CbGdCrCtD
Captopril—ABCB1—lung—hematologic cancer	0.00025	0.00427	CbGeAlD
Captopril—MMP2—Betamethasone—Prednisone—hematologic cancer	0.000243	0.122	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Prednisone—hematologic cancer	0.000243	0.122	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Prednisolone—hematologic cancer	0.000237	0.119	CbGdCrCtD
Captopril—MMP2—Betamethasone—Prednisolone—hematologic cancer	0.000237	0.119	CbGdCrCtD
Captopril—ABCB1—testis—hematologic cancer	0.000236	0.00403	CbGeAlD
Captopril—ABCB1—lymph node—hematologic cancer	0.000171	0.00292	CbGeAlD
Captopril—Nausea—Carmustine—hematologic cancer	3.24e-05	0.00014	CcSEcCtD
Captopril—Vomiting—Irinotecan—hematologic cancer	3.23e-05	0.000139	CcSEcCtD
Captopril—Vomiting—Mitoxantrone—hematologic cancer	3.23e-05	0.000139	CcSEcCtD
Captopril—Nausea—Alitretinoin—hematologic cancer	3.21e-05	0.000138	CcSEcCtD
Captopril—Agranulocytosis—Doxorubicin—hematologic cancer	3.2e-05	0.000138	CcSEcCtD
Captopril—Rash—Mitoxantrone—hematologic cancer	3.2e-05	0.000138	CcSEcCtD
Captopril—Rash—Irinotecan—hematologic cancer	3.2e-05	0.000138	CcSEcCtD
Captopril—Dermatitis—Irinotecan—hematologic cancer	3.2e-05	0.000138	CcSEcCtD
Captopril—Dermatitis—Mitoxantrone—hematologic cancer	3.2e-05	0.000138	CcSEcCtD
Captopril—Headache—Mitoxantrone—hematologic cancer	3.18e-05	0.000137	CcSEcCtD
Captopril—Headache—Irinotecan—hematologic cancer	3.18e-05	0.000137	CcSEcCtD
Captopril—Nausea—Ifosfamide—hematologic cancer	3.17e-05	0.000137	CcSEcCtD
Captopril—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.16e-05	0.000136	CcSEcCtD
Captopril—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.16e-05	0.000136	CcSEcCtD
Captopril—Arthralgia—Prednisone—hematologic cancer	3.16e-05	0.000136	CcSEcCtD
Captopril—Myalgia—Prednisone—hematologic cancer	3.16e-05	0.000136	CcSEcCtD
Captopril—Feeling abnormal—Triamcinolone—hematologic cancer	3.15e-05	0.000136	CcSEcCtD
Captopril—Diarrhoea—Cisplatin—hematologic cancer	3.15e-05	0.000136	CcSEcCtD
Captopril—Erythema multiforme—Epirubicin—hematologic cancer	3.15e-05	0.000136	CcSEcCtD
Captopril—Alopecia—Methotrexate—hematologic cancer	3.14e-05	0.000136	CcSEcCtD
Captopril—Vomiting—Gemcitabine—hematologic cancer	3.14e-05	0.000135	CcSEcCtD
Captopril—Insomnia—Dexamethasone—hematologic cancer	3.14e-05	0.000135	CcSEcCtD
Captopril—Insomnia—Betamethasone—hematologic cancer	3.14e-05	0.000135	CcSEcCtD
Captopril—Paraesthesia—Betamethasone—hematologic cancer	3.12e-05	0.000134	CcSEcCtD
Captopril—Paraesthesia—Dexamethasone—hematologic cancer	3.12e-05	0.000134	CcSEcCtD
Captopril—Discomfort—Prednisone—hematologic cancer	3.12e-05	0.000134	CcSEcCtD
Captopril—Rash—Gemcitabine—hematologic cancer	3.12e-05	0.000134	CcSEcCtD
Captopril—Dermatitis—Gemcitabine—hematologic cancer	3.11e-05	0.000134	CcSEcCtD
Captopril—Headache—Gemcitabine—hematologic cancer	3.1e-05	0.000134	CcSEcCtD
Captopril—Nausea—Vincristine—hematologic cancer	3.09e-05	0.000133	CcSEcCtD
Captopril—Flushing—Epirubicin—hematologic cancer	3.09e-05	0.000133	CcSEcCtD
Captopril—Rhinitis—Doxorubicin—hematologic cancer	3.09e-05	0.000133	CcSEcCtD
Captopril—Hepatitis—Doxorubicin—hematologic cancer	3.08e-05	0.000133	CcSEcCtD
Captopril—Pharyngitis—Doxorubicin—hematologic cancer	3.06e-05	0.000132	CcSEcCtD
Captopril—Dyspepsia—Dexamethasone—hematologic cancer	3.06e-05	0.000132	CcSEcCtD
Captopril—Dyspepsia—Betamethasone—hematologic cancer	3.06e-05	0.000132	CcSEcCtD
Captopril—Dysgeusia—Methotrexate—hematologic cancer	3.03e-05	0.000131	CcSEcCtD
Captopril—Asthenia—Etoposide—hematologic cancer	3.03e-05	0.000131	CcSEcCtD
Captopril—Body temperature increased—Triamcinolone—hematologic cancer	3.03e-05	0.00013	CcSEcCtD
Captopril—Anaphylactic shock—Prednisone—hematologic cancer	3.03e-05	0.00013	CcSEcCtD
Captopril—Decreased appetite—Dexamethasone—hematologic cancer	3.02e-05	0.00013	CcSEcCtD
Captopril—Decreased appetite—Betamethasone—hematologic cancer	3.02e-05	0.00013	CcSEcCtD
Captopril—Nausea—Mitoxantrone—hematologic cancer	3.01e-05	0.00013	CcSEcCtD
Captopril—Nausea—Irinotecan—hematologic cancer	3.01e-05	0.00013	CcSEcCtD
Captopril—Fatigue—Dexamethasone—hematologic cancer	2.99e-05	0.000129	CcSEcCtD
Captopril—Fatigue—Betamethasone—hematologic cancer	2.99e-05	0.000129	CcSEcCtD
Captopril—Pruritus—Etoposide—hematologic cancer	2.99e-05	0.000129	CcSEcCtD
Captopril—Shock—Prednisone—hematologic cancer	2.98e-05	0.000128	CcSEcCtD
Captopril—Tachycardia—Prednisone—hematologic cancer	2.95e-05	0.000127	CcSEcCtD
Captopril—Alopecia—Epirubicin—hematologic cancer	2.94e-05	0.000127	CcSEcCtD
Captopril—Nausea—Gemcitabine—hematologic cancer	2.94e-05	0.000127	CcSEcCtD
Captopril—Vomiting—Cisplatin—hematologic cancer	2.93e-05	0.000126	CcSEcCtD
Captopril—Vision blurred—Methotrexate—hematologic cancer	2.92e-05	0.000126	CcSEcCtD
Captopril—Erythema multiforme—Doxorubicin—hematologic cancer	2.91e-05	0.000126	CcSEcCtD
Captopril—Rash—Cisplatin—hematologic cancer	2.9e-05	0.000125	CcSEcCtD
Captopril—Dermatitis—Cisplatin—hematologic cancer	2.9e-05	0.000125	CcSEcCtD
Captopril—Diarrhoea—Etoposide—hematologic cancer	2.89e-05	0.000125	CcSEcCtD
Captopril—Anorexia—Prednisone—hematologic cancer	2.88e-05	0.000124	CcSEcCtD
Captopril—Ill-defined disorder—Methotrexate—hematologic cancer	2.87e-05	0.000124	CcSEcCtD
Captopril—Anaemia—Methotrexate—hematologic cancer	2.86e-05	0.000123	CcSEcCtD
Captopril—Feeling abnormal—Dexamethasone—hematologic cancer	2.86e-05	0.000123	CcSEcCtD
Captopril—Feeling abnormal—Betamethasone—hematologic cancer	2.86e-05	0.000123	CcSEcCtD
Captopril—Flushing—Doxorubicin—hematologic cancer	2.86e-05	0.000123	CcSEcCtD
Captopril—Tension—Epirubicin—hematologic cancer	2.84e-05	0.000123	CcSEcCtD
Captopril—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.84e-05	0.000122	CcSEcCtD
Captopril—Gastrointestinal pain—Betamethasone—hematologic cancer	2.84e-05	0.000122	CcSEcCtD
Captopril—Dysgeusia—Epirubicin—hematologic cancer	2.84e-05	0.000122	CcSEcCtD
Captopril—Nervousness—Epirubicin—hematologic cancer	2.82e-05	0.000121	CcSEcCtD
Captopril—Malaise—Methotrexate—hematologic cancer	2.79e-05	0.00012	CcSEcCtD
Captopril—Dizziness—Etoposide—hematologic cancer	2.79e-05	0.00012	CcSEcCtD
Captopril—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.76e-05	0.000119	CcSEcCtD
Captopril—Dizziness—Prednisolone—hematologic cancer	2.75e-05	0.000119	CcSEcCtD
Captopril—Asthenia—Triamcinolone—hematologic cancer	2.75e-05	0.000118	CcSEcCtD
Captopril—Abdominal pain—Dexamethasone—hematologic cancer	2.75e-05	0.000118	CcSEcCtD
Captopril—Body temperature increased—Dexamethasone—hematologic cancer	2.75e-05	0.000118	CcSEcCtD
Captopril—Body temperature increased—Betamethasone—hematologic cancer	2.75e-05	0.000118	CcSEcCtD
Captopril—Abdominal pain—Betamethasone—hematologic cancer	2.75e-05	0.000118	CcSEcCtD
Captopril—Nausea—Cisplatin—hematologic cancer	2.74e-05	0.000118	CcSEcCtD
Captopril—Insomnia—Prednisone—hematologic cancer	2.74e-05	0.000118	CcSEcCtD
Captopril—Vision blurred—Epirubicin—hematologic cancer	2.73e-05	0.000118	CcSEcCtD
Captopril—Alopecia—Doxorubicin—hematologic cancer	2.72e-05	0.000117	CcSEcCtD
Captopril—Paraesthesia—Prednisone—hematologic cancer	2.72e-05	0.000117	CcSEcCtD
Captopril—Pruritus—Triamcinolone—hematologic cancer	2.71e-05	0.000117	CcSEcCtD
Captopril—Cough—Methotrexate—hematologic cancer	2.7e-05	0.000117	CcSEcCtD
Captopril—Ill-defined disorder—Epirubicin—hematologic cancer	2.69e-05	0.000116	CcSEcCtD
Captopril—Vomiting—Etoposide—hematologic cancer	2.68e-05	0.000116	CcSEcCtD
Captopril—Anaemia—Epirubicin—hematologic cancer	2.68e-05	0.000116	CcSEcCtD
Captopril—Dyspepsia—Prednisone—hematologic cancer	2.66e-05	0.000115	CcSEcCtD
Captopril—Rash—Etoposide—hematologic cancer	2.66e-05	0.000115	CcSEcCtD
Captopril—Dermatitis—Etoposide—hematologic cancer	2.66e-05	0.000115	CcSEcCtD
Captopril—Headache—Etoposide—hematologic cancer	2.64e-05	0.000114	CcSEcCtD
Captopril—Arthralgia—Methotrexate—hematologic cancer	2.64e-05	0.000114	CcSEcCtD
Captopril—Myalgia—Methotrexate—hematologic cancer	2.64e-05	0.000114	CcSEcCtD
Captopril—Chest pain—Methotrexate—hematologic cancer	2.64e-05	0.000114	CcSEcCtD
Captopril—Tension—Doxorubicin—hematologic cancer	2.63e-05	0.000113	CcSEcCtD
Captopril—Decreased appetite—Prednisone—hematologic cancer	2.63e-05	0.000113	CcSEcCtD
Captopril—Dysgeusia—Doxorubicin—hematologic cancer	2.63e-05	0.000113	CcSEcCtD
Captopril—Rash—Prednisolone—hematologic cancer	2.62e-05	0.000113	CcSEcCtD
Captopril—Dermatitis—Prednisolone—hematologic cancer	2.62e-05	0.000113	CcSEcCtD
Captopril—Malaise—Epirubicin—hematologic cancer	2.61e-05	0.000113	CcSEcCtD
Captopril—Fatigue—Prednisone—hematologic cancer	2.61e-05	0.000112	CcSEcCtD
Captopril—Headache—Prednisolone—hematologic cancer	2.61e-05	0.000112	CcSEcCtD
Captopril—Discomfort—Methotrexate—hematologic cancer	2.61e-05	0.000112	CcSEcCtD
Captopril—Nervousness—Doxorubicin—hematologic cancer	2.61e-05	0.000112	CcSEcCtD
Captopril—Syncope—Epirubicin—hematologic cancer	2.6e-05	0.000112	CcSEcCtD
Captopril—Constipation—Prednisone—hematologic cancer	2.59e-05	0.000112	CcSEcCtD
Captopril—Palpitations—Epirubicin—hematologic cancer	2.56e-05	0.00011	CcSEcCtD
Captopril—Confusional state—Methotrexate—hematologic cancer	2.55e-05	0.00011	CcSEcCtD
Captopril—Loss of consciousness—Epirubicin—hematologic cancer	2.55e-05	0.00011	CcSEcCtD
Captopril—Dizziness—Triamcinolone—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Captopril—Cough—Epirubicin—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Captopril—Anaphylactic shock—Methotrexate—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Captopril—Vision blurred—Doxorubicin—hematologic cancer	2.53e-05	0.000109	CcSEcCtD
Captopril—Nausea—Etoposide—hematologic cancer	2.51e-05	0.000108	CcSEcCtD
Captopril—Feeling abnormal—Prednisone—hematologic cancer	2.49e-05	0.000107	CcSEcCtD
Captopril—Asthenia—Betamethasone—hematologic cancer	2.49e-05	0.000107	CcSEcCtD
Captopril—Asthenia—Dexamethasone—hematologic cancer	2.49e-05	0.000107	CcSEcCtD
Captopril—Ill-defined disorder—Doxorubicin—hematologic cancer	2.49e-05	0.000107	CcSEcCtD
Captopril—Anaemia—Doxorubicin—hematologic cancer	2.48e-05	0.000107	CcSEcCtD
Captopril—Thrombocytopenia—Methotrexate—hematologic cancer	2.48e-05	0.000107	CcSEcCtD
Captopril—Gastrointestinal pain—Prednisone—hematologic cancer	2.47e-05	0.000107	CcSEcCtD
Captopril—Nausea—Prednisolone—hematologic cancer	2.47e-05	0.000107	CcSEcCtD
Captopril—Arthralgia—Epirubicin—hematologic cancer	2.47e-05	0.000106	CcSEcCtD
Captopril—Chest pain—Epirubicin—hematologic cancer	2.47e-05	0.000106	CcSEcCtD
Captopril—Myalgia—Epirubicin—hematologic cancer	2.47e-05	0.000106	CcSEcCtD
Captopril—Pruritus—Dexamethasone—hematologic cancer	2.46e-05	0.000106	CcSEcCtD
Captopril—Pruritus—Betamethasone—hematologic cancer	2.46e-05	0.000106	CcSEcCtD
Captopril—Discomfort—Epirubicin—hematologic cancer	2.44e-05	0.000105	CcSEcCtD
Captopril—Vomiting—Triamcinolone—hematologic cancer	2.43e-05	0.000105	CcSEcCtD
Captopril—Malaise—Doxorubicin—hematologic cancer	2.42e-05	0.000104	CcSEcCtD
Captopril—Rash—Triamcinolone—hematologic cancer	2.41e-05	0.000104	CcSEcCtD
Captopril—Dry mouth—Epirubicin—hematologic cancer	2.41e-05	0.000104	CcSEcCtD
Captopril—Dermatitis—Triamcinolone—hematologic cancer	2.41e-05	0.000104	CcSEcCtD
Captopril—Anorexia—Methotrexate—hematologic cancer	2.41e-05	0.000104	CcSEcCtD
Captopril—Syncope—Doxorubicin—hematologic cancer	2.41e-05	0.000104	CcSEcCtD
Captopril—Headache—Triamcinolone—hematologic cancer	2.4e-05	0.000103	CcSEcCtD
Captopril—Body temperature increased—Prednisone—hematologic cancer	2.39e-05	0.000103	CcSEcCtD
Captopril—Abdominal pain—Prednisone—hematologic cancer	2.39e-05	0.000103	CcSEcCtD
Captopril—Confusional state—Epirubicin—hematologic cancer	2.39e-05	0.000103	CcSEcCtD
Captopril—Diarrhoea—Betamethasone—hematologic cancer	2.38e-05	0.000102	CcSEcCtD
Captopril—Diarrhoea—Dexamethasone—hematologic cancer	2.38e-05	0.000102	CcSEcCtD
Captopril—Palpitations—Doxorubicin—hematologic cancer	2.37e-05	0.000102	CcSEcCtD
Captopril—Anaphylactic shock—Epirubicin—hematologic cancer	2.37e-05	0.000102	CcSEcCtD
Captopril—Hypotension—Methotrexate—hematologic cancer	2.36e-05	0.000102	CcSEcCtD
Captopril—Loss of consciousness—Doxorubicin—hematologic cancer	2.36e-05	0.000102	CcSEcCtD
Captopril—Cough—Doxorubicin—hematologic cancer	2.34e-05	0.000101	CcSEcCtD
Captopril—Shock—Epirubicin—hematologic cancer	2.33e-05	0.0001	CcSEcCtD
Captopril—Thrombocytopenia—Epirubicin—hematologic cancer	2.32e-05	9.99e-05	CcSEcCtD
Captopril—Tachycardia—Epirubicin—hematologic cancer	2.31e-05	9.96e-05	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.3e-05	9.93e-05	CcSEcCtD
Captopril—Dizziness—Dexamethasone—hematologic cancer	2.3e-05	9.9e-05	CcSEcCtD
Captopril—Dizziness—Betamethasone—hematologic cancer	2.3e-05	9.9e-05	CcSEcCtD
Captopril—Insomnia—Methotrexate—hematologic cancer	2.29e-05	9.86e-05	CcSEcCtD
Captopril—Chest pain—Doxorubicin—hematologic cancer	2.28e-05	9.85e-05	CcSEcCtD
Captopril—Arthralgia—Doxorubicin—hematologic cancer	2.28e-05	9.85e-05	CcSEcCtD
Captopril—Myalgia—Doxorubicin—hematologic cancer	2.28e-05	9.85e-05	CcSEcCtD
Captopril—Nausea—Triamcinolone—hematologic cancer	2.27e-05	9.8e-05	CcSEcCtD
Captopril—Paraesthesia—Methotrexate—hematologic cancer	2.27e-05	9.79e-05	CcSEcCtD
Captopril—Discomfort—Doxorubicin—hematologic cancer	2.26e-05	9.73e-05	CcSEcCtD
Captopril—Anorexia—Epirubicin—hematologic cancer	2.26e-05	9.72e-05	CcSEcCtD
Captopril—Dyspnoea—Methotrexate—hematologic cancer	2.25e-05	9.72e-05	CcSEcCtD
Captopril—Somnolence—Methotrexate—hematologic cancer	2.25e-05	9.69e-05	CcSEcCtD
Captopril—Dry mouth—Doxorubicin—hematologic cancer	2.23e-05	9.63e-05	CcSEcCtD
Captopril—Dyspepsia—Methotrexate—hematologic cancer	2.23e-05	9.59e-05	CcSEcCtD
Captopril—Hypotension—Epirubicin—hematologic cancer	2.21e-05	9.53e-05	CcSEcCtD
Captopril—Vomiting—Betamethasone—hematologic cancer	2.21e-05	9.52e-05	CcSEcCtD
Captopril—Vomiting—Dexamethasone—hematologic cancer	2.21e-05	9.52e-05	CcSEcCtD
Captopril—Confusional state—Doxorubicin—hematologic cancer	2.21e-05	9.52e-05	CcSEcCtD
Captopril—Decreased appetite—Methotrexate—hematologic cancer	2.2e-05	9.48e-05	CcSEcCtD
Captopril—Rash—Dexamethasone—hematologic cancer	2.19e-05	9.44e-05	CcSEcCtD
Captopril—Rash—Betamethasone—hematologic cancer	2.19e-05	9.44e-05	CcSEcCtD
Captopril—Anaphylactic shock—Doxorubicin—hematologic cancer	2.19e-05	9.44e-05	CcSEcCtD
Captopril—Dermatitis—Dexamethasone—hematologic cancer	2.19e-05	9.43e-05	CcSEcCtD
Captopril—Dermatitis—Betamethasone—hematologic cancer	2.19e-05	9.43e-05	CcSEcCtD
Captopril—Fatigue—Methotrexate—hematologic cancer	2.18e-05	9.4e-05	CcSEcCtD
Captopril—Headache—Betamethasone—hematologic cancer	2.18e-05	9.38e-05	CcSEcCtD
Captopril—Headache—Dexamethasone—hematologic cancer	2.18e-05	9.38e-05	CcSEcCtD
Captopril—Asthenia—Prednisone—hematologic cancer	2.17e-05	9.36e-05	CcSEcCtD
Captopril—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.16e-05	9.29e-05	CcSEcCtD
Captopril—Shock—Doxorubicin—hematologic cancer	2.15e-05	9.29e-05	CcSEcCtD
Captopril—Thrombocytopenia—Doxorubicin—hematologic cancer	2.14e-05	9.24e-05	CcSEcCtD
Captopril—Pruritus—Prednisone—hematologic cancer	2.14e-05	9.23e-05	CcSEcCtD
Captopril—Insomnia—Epirubicin—hematologic cancer	2.14e-05	9.23e-05	CcSEcCtD
Captopril—Tachycardia—Doxorubicin—hematologic cancer	2.14e-05	9.21e-05	CcSEcCtD
Captopril—Paraesthesia—Epirubicin—hematologic cancer	2.12e-05	9.16e-05	CcSEcCtD
Captopril—Dyspnoea—Epirubicin—hematologic cancer	2.11e-05	9.09e-05	CcSEcCtD
Captopril—Somnolence—Epirubicin—hematologic cancer	2.1e-05	9.07e-05	CcSEcCtD
Captopril—Anorexia—Doxorubicin—hematologic cancer	2.09e-05	9e-05	CcSEcCtD
Captopril—Feeling abnormal—Methotrexate—hematologic cancer	2.08e-05	8.98e-05	CcSEcCtD
Captopril—Dyspepsia—Epirubicin—hematologic cancer	2.08e-05	8.98e-05	CcSEcCtD
Captopril—Diarrhoea—Prednisone—hematologic cancer	2.07e-05	8.92e-05	CcSEcCtD
Captopril—Gastrointestinal pain—Methotrexate—hematologic cancer	2.07e-05	8.91e-05	CcSEcCtD
Captopril—Nausea—Dexamethasone—hematologic cancer	2.06e-05	8.9e-05	CcSEcCtD
Captopril—Nausea—Betamethasone—hematologic cancer	2.06e-05	8.9e-05	CcSEcCtD
Captopril—Decreased appetite—Epirubicin—hematologic cancer	2.06e-05	8.87e-05	CcSEcCtD
Captopril—Hypotension—Doxorubicin—hematologic cancer	2.05e-05	8.82e-05	CcSEcCtD
Captopril—Fatigue—Epirubicin—hematologic cancer	2.04e-05	8.79e-05	CcSEcCtD
Captopril—Constipation—Epirubicin—hematologic cancer	2.02e-05	8.72e-05	CcSEcCtD
Captopril—Dizziness—Prednisone—hematologic cancer	2e-05	8.62e-05	CcSEcCtD
Captopril—Body temperature increased—Methotrexate—hematologic cancer	2e-05	8.62e-05	CcSEcCtD
Captopril—Abdominal pain—Methotrexate—hematologic cancer	2e-05	8.62e-05	CcSEcCtD
Captopril—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.99e-05	8.6e-05	CcSEcCtD
Captopril—Insomnia—Doxorubicin—hematologic cancer	1.98e-05	8.54e-05	CcSEcCtD
Captopril—Paraesthesia—Doxorubicin—hematologic cancer	1.97e-05	8.48e-05	CcSEcCtD
Captopril—Dyspnoea—Doxorubicin—hematologic cancer	1.95e-05	8.41e-05	CcSEcCtD
Captopril—Feeling abnormal—Epirubicin—hematologic cancer	1.95e-05	8.41e-05	CcSEcCtD
Captopril—Somnolence—Doxorubicin—hematologic cancer	1.95e-05	8.39e-05	CcSEcCtD
Captopril—Gastrointestinal pain—Epirubicin—hematologic cancer	1.93e-05	8.34e-05	CcSEcCtD
Captopril—Dyspepsia—Doxorubicin—hematologic cancer	1.93e-05	8.31e-05	CcSEcCtD
Captopril—Vomiting—Prednisone—hematologic cancer	1.92e-05	8.29e-05	CcSEcCtD
Captopril—Rash—Prednisone—hematologic cancer	1.91e-05	8.22e-05	CcSEcCtD
Captopril—Dermatitis—Prednisone—hematologic cancer	1.91e-05	8.22e-05	CcSEcCtD
Captopril—Decreased appetite—Doxorubicin—hematologic cancer	1.9e-05	8.2e-05	CcSEcCtD
Captopril—Headache—Prednisone—hematologic cancer	1.9e-05	8.17e-05	CcSEcCtD
Captopril—Fatigue—Doxorubicin—hematologic cancer	1.89e-05	8.14e-05	CcSEcCtD
Captopril—Constipation—Doxorubicin—hematologic cancer	1.87e-05	8.07e-05	CcSEcCtD
Captopril—Body temperature increased—Epirubicin—hematologic cancer	1.87e-05	8.06e-05	CcSEcCtD
Captopril—Abdominal pain—Epirubicin—hematologic cancer	1.87e-05	8.06e-05	CcSEcCtD
Captopril—Asthenia—Methotrexate—hematologic cancer	1.81e-05	7.82e-05	CcSEcCtD
Captopril—Feeling abnormal—Doxorubicin—hematologic cancer	1.8e-05	7.78e-05	CcSEcCtD
Captopril—Nausea—Prednisone—hematologic cancer	1.8e-05	7.75e-05	CcSEcCtD
Captopril—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.79e-05	7.72e-05	CcSEcCtD
Captopril—Pruritus—Methotrexate—hematologic cancer	1.79e-05	7.71e-05	CcSEcCtD
Captopril—Abdominal pain—Doxorubicin—hematologic cancer	1.73e-05	7.46e-05	CcSEcCtD
Captopril—Body temperature increased—Doxorubicin—hematologic cancer	1.73e-05	7.46e-05	CcSEcCtD
Captopril—Diarrhoea—Methotrexate—hematologic cancer	1.73e-05	7.46e-05	CcSEcCtD
Captopril—Asthenia—Epirubicin—hematologic cancer	1.7e-05	7.32e-05	CcSEcCtD
Captopril—Pruritus—Epirubicin—hematologic cancer	1.67e-05	7.22e-05	CcSEcCtD
Captopril—Dizziness—Methotrexate—hematologic cancer	1.67e-05	7.21e-05	CcSEcCtD
Captopril—Diarrhoea—Epirubicin—hematologic cancer	1.62e-05	6.98e-05	CcSEcCtD
Captopril—Vomiting—Methotrexate—hematologic cancer	1.61e-05	6.93e-05	CcSEcCtD
Captopril—Rash—Methotrexate—hematologic cancer	1.59e-05	6.87e-05	CcSEcCtD
Captopril—Dermatitis—Methotrexate—hematologic cancer	1.59e-05	6.87e-05	CcSEcCtD
Captopril—Headache—Methotrexate—hematologic cancer	1.58e-05	6.83e-05	CcSEcCtD
Captopril—Asthenia—Doxorubicin—hematologic cancer	1.57e-05	6.77e-05	CcSEcCtD
Captopril—Dizziness—Epirubicin—hematologic cancer	1.56e-05	6.75e-05	CcSEcCtD
Captopril—Pruritus—Doxorubicin—hematologic cancer	1.55e-05	6.68e-05	CcSEcCtD
Captopril—Vomiting—Epirubicin—hematologic cancer	1.5e-05	6.49e-05	CcSEcCtD
Captopril—Nausea—Methotrexate—hematologic cancer	1.5e-05	6.47e-05	CcSEcCtD
Captopril—Diarrhoea—Doxorubicin—hematologic cancer	1.5e-05	6.46e-05	CcSEcCtD
Captopril—Rash—Epirubicin—hematologic cancer	1.49e-05	6.43e-05	CcSEcCtD
Captopril—Dermatitis—Epirubicin—hematologic cancer	1.49e-05	6.43e-05	CcSEcCtD
Captopril—Headache—Epirubicin—hematologic cancer	1.48e-05	6.39e-05	CcSEcCtD
Captopril—Dizziness—Doxorubicin—hematologic cancer	1.45e-05	6.24e-05	CcSEcCtD
Captopril—Nausea—Epirubicin—hematologic cancer	1.41e-05	6.06e-05	CcSEcCtD
Captopril—Vomiting—Doxorubicin—hematologic cancer	1.39e-05	6e-05	CcSEcCtD
Captopril—Rash—Doxorubicin—hematologic cancer	1.38e-05	5.95e-05	CcSEcCtD
Captopril—Dermatitis—Doxorubicin—hematologic cancer	1.38e-05	5.95e-05	CcSEcCtD
Captopril—Headache—Doxorubicin—hematologic cancer	1.37e-05	5.91e-05	CcSEcCtD
Captopril—Nausea—Doxorubicin—hematologic cancer	1.3e-05	5.61e-05	CcSEcCtD
Captopril—CYP2D6—Metabolism—HMMR—hematologic cancer	4.98e-06	3.05e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ARNTL—hematologic cancer	4.97e-06	3.04e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	4.94e-06	3.02e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CREB1—hematologic cancer	4.89e-06	2.99e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	4.88e-06	2.98e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	4.86e-06	2.97e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—FN1—hematologic cancer	4.85e-06	2.96e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ACP5—hematologic cancer	4.83e-06	2.96e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CA9—hematologic cancer	4.83e-06	2.96e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—BRAF—hematologic cancer	4.82e-06	2.95e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—UGT1A1—hematologic cancer	4.82e-06	2.95e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL2—hematologic cancer	4.78e-06	2.92e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NCOR2—hematologic cancer	4.77e-06	2.92e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6R—hematologic cancer	4.77e-06	2.91e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CREBBP—hematologic cancer	4.76e-06	2.91e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2RA—hematologic cancer	4.76e-06	2.91e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2—hematologic cancer	4.72e-06	2.89e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TERT—hematologic cancer	4.7e-06	2.88e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC22A1—hematologic cancer	4.69e-06	2.87e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CRABP1—hematologic cancer	4.69e-06	2.87e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ARNTL—hematologic cancer	4.68e-06	2.86e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CG—hematologic cancer	4.64e-06	2.84e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PDGFB—hematologic cancer	4.59e-06	2.81e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ALOX5—hematologic cancer	4.57e-06	2.8e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PTPN11—hematologic cancer	4.56e-06	2.79e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CA9—hematologic cancer	4.55e-06	2.79e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ACP5—hematologic cancer	4.55e-06	2.79e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—IDH1—hematologic cancer	4.54e-06	2.78e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAP2K1—hematologic cancer	4.54e-06	2.78e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.54e-06	2.78e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CD—hematologic cancer	4.51e-06	2.76e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.51e-06	2.75e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NCOR2—hematologic cancer	4.5e-06	2.75e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ABCC3—hematologic cancer	4.49e-06	2.75e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TXN—hematologic cancer	4.49e-06	2.75e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTO1—hematologic cancer	4.49e-06	2.75e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TSC2—hematologic cancer	4.49e-06	2.74e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—hematologic cancer	4.46e-06	2.73e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NUP98—hematologic cancer	4.43e-06	2.71e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SPHK1—hematologic cancer	4.4e-06	2.69e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGF2—hematologic cancer	4.32e-06	2.64e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGFR3—hematologic cancer	4.32e-06	2.64e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—CREBBP—hematologic cancer	4.3e-06	2.63e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ADCY7—hematologic cancer	4.3e-06	2.63e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NCOA3—hematologic cancer	4.3e-06	2.63e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—IDH1—hematologic cancer	4.28e-06	2.62e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK14—hematologic cancer	4.27e-06	2.61e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NUP214—hematologic cancer	4.27e-06	2.61e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3R1—hematologic cancer	4.26e-06	2.61e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TXN—hematologic cancer	4.23e-06	2.59e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCC3—hematologic cancer	4.23e-06	2.59e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTO1—hematologic cancer	4.23e-06	2.59e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.22e-06	2.58e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.22e-06	2.58e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	4.2e-06	2.57e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ESR1—hematologic cancer	4.19e-06	2.56e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MTR—hematologic cancer	4.18e-06	2.56e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCG2—hematologic cancer	4.18e-06	2.56e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SPHK1—hematologic cancer	4.14e-06	2.53e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FN1—hematologic cancer	4.14e-06	2.53e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—JAK2—hematologic cancer	4.14e-06	2.53e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.14e-06	2.53e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CRABP1—hematologic cancer	4.11e-06	2.51e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.11e-06	2.51e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ENO2—hematologic cancer	4.1e-06	2.51e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NFKBIA—hematologic cancer	4.09e-06	2.5e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BAD—hematologic cancer	4.09e-06	2.5e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CD—hematologic cancer	4.08e-06	2.49e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH1—hematologic cancer	4.05e-06	2.48e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MDM2—hematologic cancer	4.04e-06	2.47e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALOX5—hematologic cancer	4e-06	2.45e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4e-06	2.45e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—UGT1A1—hematologic cancer	3.98e-06	2.43e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTT1—hematologic cancer	3.98e-06	2.43e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CD80—hematologic cancer	3.97e-06	2.43e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CG—hematologic cancer	3.96e-06	2.42e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KIT—hematologic cancer	3.96e-06	2.42e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—NRAS—hematologic cancer	3.96e-06	2.42e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CB—hematologic cancer	3.93e-06	2.41e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MTOR—hematologic cancer	3.93e-06	2.41e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.92e-06	2.39e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTPN11—hematologic cancer	3.89e-06	2.38e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SDC1—hematologic cancer	3.89e-06	2.38e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NUP98—hematologic cancer	3.88e-06	2.37e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC22A1—hematologic cancer	3.87e-06	2.37e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CRABP1—hematologic cancer	3.87e-06	2.37e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3R1—hematologic cancer	3.85e-06	2.35e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MAPK3—hematologic cancer	3.8e-06	2.32e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALOX5—hematologic cancer	3.77e-06	2.31e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CREB1—hematologic cancer	3.77e-06	2.31e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ADCY7—hematologic cancer	3.77e-06	2.3e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NCOA3—hematologic cancer	3.77e-06	2.3e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—JAK2—hematologic cancer	3.74e-06	2.29e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NUP214—hematologic cancer	3.74e-06	2.29e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BRAF—hematologic cancer	3.73e-06	2.28e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.72e-06	2.28e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.71e-06	2.27e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL2—hematologic cancer	3.69e-06	2.26e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1B—hematologic cancer	3.69e-06	2.26e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6R—hematologic cancer	3.68e-06	2.25e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CREBBP—hematologic cancer	3.67e-06	2.25e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ABCG2—hematologic cancer	3.66e-06	2.24e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTR—hematologic cancer	3.66e-06	2.24e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NUP98—hematologic cancer	3.66e-06	2.24e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CASP3—hematologic cancer	3.62e-06	2.21e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—hematologic cancer	3.61e-06	2.21e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ENO2—hematologic cancer	3.59e-06	2.2e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CB—hematologic cancer	3.55e-06	2.17e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ADCY7—hematologic cancer	3.55e-06	2.17e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NCOA3—hematologic cancer	3.55e-06	2.17e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NUP214—hematologic cancer	3.52e-06	2.15e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCND1—hematologic cancer	3.52e-06	2.15e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—JUN—hematologic cancer	3.51e-06	2.15e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAP2K1—hematologic cancer	3.51e-06	2.14e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.51e-06	2.14e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CD—hematologic cancer	3.48e-06	2.13e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTT1—hematologic cancer	3.48e-06	2.13e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTR—hematologic cancer	3.45e-06	2.11e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCG2—hematologic cancer	3.45e-06	2.11e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CA—hematologic cancer	3.45e-06	2.11e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	3.43e-06	2.1e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—KRAS—hematologic cancer	3.41e-06	2.09e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1A—hematologic cancer	3.41e-06	2.08e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SDC1—hematologic cancer	3.41e-06	2.08e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTEN—hematologic cancer	3.4e-06	2.08e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ENO2—hematologic cancer	3.38e-06	2.07e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.38e-06	2.07e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGF2—hematologic cancer	3.34e-06	2.04e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK8—hematologic cancer	3.32e-06	2.03e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CD44—hematologic cancer	3.3e-06	2.02e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NQO1—hematologic cancer	3.3e-06	2.02e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3R1—hematologic cancer	3.29e-06	2.01e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.28e-06	2.01e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—hematologic cancer	3.26e-06	2e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.26e-06	1.99e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EP300—hematologic cancer	3.24e-06	1.98e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.24e-06	1.98e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SDC1—hematologic cancer	3.21e-06	1.96e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JAK2—hematologic cancer	3.2e-06	1.96e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SRC—hematologic cancer	3.15e-06	1.93e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CA—hematologic cancer	3.13e-06	1.92e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYCS—hematologic cancer	3.13e-06	1.91e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MDM2—hematologic cancer	3.12e-06	1.91e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HSP90AA1—hematologic cancer	3.11e-06	1.9e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—hematologic cancer	3.07e-06	1.88e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.05e-06	1.87e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT3—hematologic cancer	3.04e-06	1.86e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MTOR—hematologic cancer	3.04e-06	1.86e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CB—hematologic cancer	3.04e-06	1.86e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NRAS—hematologic cancer	3.03e-06	1.85e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—EP300—hematologic cancer	2.93e-06	1.79e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK3—hematologic cancer	2.9e-06	1.78e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRAS—hematologic cancer	2.9e-06	1.77e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CD44—hematologic cancer	2.9e-06	1.77e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NQO1—hematologic cancer	2.9e-06	1.77e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1B—hematologic cancer	2.85e-06	1.74e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—SRC—hematologic cancer	2.85e-06	1.74e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—hematologic cancer	2.82e-06	1.73e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—hematologic cancer	2.82e-06	1.72e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—hematologic cancer	2.82e-06	1.72e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.8e-06	1.71e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CASP3—hematologic cancer	2.79e-06	1.71e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—hematologic cancer	2.79e-06	1.71e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—hematologic cancer	2.78e-06	1.7e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—hematologic cancer	2.77e-06	1.7e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTP1—hematologic cancer	2.76e-06	1.69e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NRAS—hematologic cancer	2.74e-06	1.68e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYCS—hematologic cancer	2.74e-06	1.68e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NQO1—hematologic cancer	2.73e-06	1.67e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CD44—hematologic cancer	2.73e-06	1.67e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.72e-06	1.66e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCND1—hematologic cancer	2.72e-06	1.66e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JUN—hematologic cancer	2.71e-06	1.66e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.67e-06	1.63e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1A—hematologic cancer	2.63e-06	1.61e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—MAPK3—hematologic cancer	2.62e-06	1.6e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTEN—hematologic cancer	2.62e-06	1.6e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KRAS—hematologic cancer	2.61e-06	1.6e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCB1—hematologic cancer	2.61e-06	1.6e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYCS—hematologic cancer	2.58e-06	1.58e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK8—hematologic cancer	2.57e-06	1.57e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.57e-06	1.57e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—hematologic cancer	2.56e-06	1.57e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—hematologic cancer	2.55e-06	1.56e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NCOR1—hematologic cancer	2.53e-06	1.55e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTM1—hematologic cancer	2.53e-06	1.55e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EP300—hematologic cancer	2.5e-06	1.53e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SRC—hematologic cancer	2.43e-06	1.49e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTP1—hematologic cancer	2.41e-06	1.48e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CA—hematologic cancer	2.4e-06	1.47e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—hematologic cancer	2.37e-06	1.45e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—KRAS—hematologic cancer	2.36e-06	1.44e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT3—hematologic cancer	2.35e-06	1.44e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NRAS—hematologic cancer	2.34e-06	1.43e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—hematologic cancer	2.32e-06	1.42e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.28e-06	1.39e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK3—hematologic cancer	2.24e-06	1.37e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MTHFR—hematologic cancer	2.24e-06	1.37e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTM1—hematologic cancer	2.22e-06	1.36e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NCOR1—hematologic cancer	2.22e-06	1.36e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRAS—hematologic cancer	2.22e-06	1.36e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—hematologic cancer	2.18e-06	1.33e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—hematologic cancer	2.18e-06	1.33e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CA—hematologic cancer	2.17e-06	1.32e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.15e-06	1.32e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—hematologic cancer	2.12e-06	1.3e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—hematologic cancer	2.1e-06	1.28e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.09e-06	1.28e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.09e-06	1.28e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KRAS—hematologic cancer	2.02e-06	1.23e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—HRAS—hematologic cancer	2e-06	1.23e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.97e-06	1.21e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTHFR—hematologic cancer	1.96e-06	1.2e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—hematologic cancer	1.96e-06	1.2e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CG—hematologic cancer	1.88e-06	1.15e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CA—hematologic cancer	1.85e-06	1.13e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.85e-06	1.13e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—hematologic cancer	1.79e-06	1.1e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—hematologic cancer	1.77e-06	1.08e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CREBBP—hematologic cancer	1.74e-06	1.07e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRAS—hematologic cancer	1.71e-06	1.05e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CD—hematologic cancer	1.65e-06	1.01e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.65e-06	1.01e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—hematologic cancer	1.64e-06	1e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3R1—hematologic cancer	1.56e-06	9.55e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.55e-06	9.5e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CREBBP—hematologic cancer	1.53e-06	9.34e-06	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—hematologic cancer	1.51e-06	9.25e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.45e-06	8.86e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CB—hematologic cancer	1.44e-06	8.81e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.44e-06	8.8e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALB—hematologic cancer	1.43e-06	8.74e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.37e-06	8.36e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.37e-06	8.35e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALB—hematologic cancer	1.35e-06	8.24e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.29e-06	7.88e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.26e-06	7.72e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—PTEN—hematologic cancer	1.25e-06	7.61e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.19e-06	7.28e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—EP300—hematologic cancer	1.19e-06	7.26e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTEN—hematologic cancer	1.09e-06	6.67e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—EP300—hematologic cancer	1.04e-06	6.36e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTEN—hematologic cancer	1.03e-06	6.29e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—EP300—hematologic cancer	9.81e-07	6e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CA—hematologic cancer	8.78e-07	5.37e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.7e-07	4.71e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.25e-07	4.44e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—hematologic cancer	7.18e-07	4.39e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—hematologic cancer	6.29e-07	3.85e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—hematologic cancer	5.93e-07	3.62e-06	CbGpPWpGaD
